AstraZeneca Plc $AZN, one of the leading pharmaceutical companies worldwide, has lost its status as the most valuable company listed on the London Stock Exchange. This event is a direct consequence of the stock market's reaction to changes proposed by the administration of U.S. President Donald Trump regarding drug price reductions.